Aegerion Pharmaceuticals, Inc. to Webcast Investor Event

Published: Oct 22, 2012

CAMBRIDGE, Mass., Oct. 19, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will host an investor event consisting of a company presentation and a discussion by several physicians in the field of lipidology. The event will be held on Tuesday, October 23, with the webcast scheduled to begin at approximately 3:00 p.m. EDT.

Back to news